Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 547

1.

Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma of the head and neck.

Law A, Kennedy T, Pellitteri P, Wood C, Christie D, Yumen O.

Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1361-8. Epub 2007 Sep 14.

PMID:
17869022
2.

Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.

Haddad R, Sonis S, Posner M, Wirth L, Costello R, Braschayko P, Allen A, Mahadevan A, Flynn J, Burke E, Li Y, Tishler RB.

Cancer. 2009 Oct 1;115(19):4514-23. doi: 10.1002/cncr.24525.

4.

A Phase II trial of subcutaneous amifostine and radiation therapy in patients with head-and-neck cancer.

Anné PR, Machtay M, Rosenthal DI, Brizel DM, Morrison WH, Irwin DH, Chougule PB, Estopinal NC, Berson A, Curran WJ Jr.

Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):445-52. Epub 2006 Dec 4.

PMID:
17141978
5.

Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study.

Buentzel J, Micke O, Adamietz IA, Monnier A, Glatzel M, de Vries A.

Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):684-91. Epub 2005 Oct 21.

PMID:
16243440
6.

Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer.

Antonadou D, Pepelassi M, Synodinou M, Puglisi M, Throuvalas N.

Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):739-47.

PMID:
11849797
7.
8.

Feasibility and efficacy of subcutaneous amifostine therapy in patients with head and neck cancer treated with curative accelerated concomitant-boost radiation therapy.

Ozsahin M, Betz M, Matzinger O, Bron L, Luthi F, Pasche P, Azria D, Mirimanoff RO, Zouhair A.

Arch Otolaryngol Head Neck Surg. 2006 Feb;132(2):141-5.

PMID:
16490870
9.

Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer.

Büntzel J, Glatzel M, Kuttner K, Weinaug R, Fröhlich D.

Semin Radiat Oncol. 2002 Jan;12(1 Suppl 1):4-13.

PMID:
11917277
10.
12.

Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.

Machtay M, Rosenthal DI, Chalian AA, Lustig R, Hershock D, Miller L, Weinstein GS, Weber RS.

Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):72-7.

PMID:
15093901
13.

Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients.

Rades D, Fehlauer F, Bajrovic A, Mahlmann B, Richter E, Alberti W.

Radiother Oncol. 2004 Mar;70(3):261-4.

PMID:
15064010
15.

Preliminary data of the GORTEC 2000-02 phase III trial comparing intravenous and subcutaneous administration of amifostine for head and neck tumors treated by external radiotherapy.

Bardet E, Martin L, Calais G, Tuchais C, Bourhis J, Rhein B, Feham N, Alphonsi M.

Semin Oncol. 2002 Dec;29(6 Suppl 19):57-60.

PMID:
12577246
16.

[Cytoprotection with amifostine in the framework of radiochemotherapy in previously irradiated head and neck carcinoma].

Büntzel J, Glatzel M, Schuth J, Weinaug R, Küttner K, Fröhlich D.

Strahlenther Onkol. 1999 Nov;175 Suppl 4:37-40. German.

PMID:
10584140
17.

The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck.

Suntharalingam M, Haas ML, Conley BA, Egorin MJ, Levy S, Sivasailam S, Herman JM, Jacobs MC, Gray WC, Ord RA, Aisner JA, Van Echo DA.

Int J Radiat Oncol Biol Phys. 2000 Apr 1;47(1):49-56.

PMID:
10758304
18.

Randomized double-blind trial of combined modality treatment with or without amifostine in unresectable stage III non-small-cell lung cancer.

Leong SS, Tan EH, Fong KW, Wilder-Smith E, Ong YK, Tai BC, Chew L, Lim SH, Wee J, Lee KM, Foo KF, Ang P, Ang PT.

J Clin Oncol. 2003 May 1;21(9):1767-74.

PMID:
12721253
19.

Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non-small-cell lung cancer.

Antonadou D, Throuvalas N, Petridis A, Bolanos N, Sagriotis A, Synodinou M.

Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):402-8.

PMID:
12957251
20.

A phase II trial of subcutaneous amifostine and radiation therapy in patients with head and neck cancer.

Anné PR, Curran WJ Jr.

Semin Radiat Oncol. 2002 Jan;12(1 Suppl 1):18-9.

PMID:
11917279

Supplemental Content

Support Center